Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 4Other hematologic neoplasm 3Myeloid 3Breast 3Other neoplasm 2Endocrine 2CNS 2NET 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Lymphoma 2569Precursor Cell Lymphoblastic Leukemia-Lymphoma 2084Lymphoma, Non-Hodgkin 2055Leukemia, Lymphocytic, Chronic, B-Cell 1771Lymphoma, Follicular 1651Lymphoma, Large B-Cell, Diffuse 1596Leukemia 1170Hodgkin Disease 1127Lymphoma, Mantle-Cell 1110Burkitt Lymphoma 887Leukemia, Myeloid, Acute 884Lymphoma, B-Cell, Marginal Zone 788Recurrence 777Multiple Myeloma 744Lymphoma, B-Cell 702Myelodysplastic Syndromes 614Neoplasms 492Lymphoma, T-Cell, Cutaneous 479Waldenstrom Macroglobulinemia 470Lymphoma, Large-Cell, Immunoblastic 456Mycosis Fungoides 383Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Lymphoma, Large-Cell, Anaplastic 362Sezary Syndrome 321Lymphoma, T-Cell, Peripheral 320Leukemia, Myelogenous, Chronic, BCR-ABL Positive 307Hematologic Neoplasms 298Myeloproliferative Disorders 288Neoplasms, Plasma Cell 270Blast Crisis 261

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pathologic Processes × Lymphoid × Clear all
NCT04601584 2024-03-06

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

AO GENERIUM

Phase 1/2 Unknown
36 enrolled
LymphoidOther hematologic neoplasm

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡